Results 11 to 20 of about 51,322 (300)
Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients [PDF]
Anais Brasileiros de Dermatologia, 2014 BACKGROUND: aAlthough rare, bullous pemphigoid (BP) is the most common autoimmune blistering disease. Recent studies have shown that patients with bullous pemphigoid are more likely to have neurological and psychiatric diseases, particularly prior to the
Vera Barreto Teixeira +4 more
doaj +4 more sources
Anais Brasileiros de Dermatologia, 2019 Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects elderly individuals. Increase in incidence rates in the past decades has been attributed to population aging, drug-induced cases and improvement in the diagnosis of the
D. Miyamoto +3 more
semanticscholar +6 more sources
Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
Frontiers in Immunology, 2022 Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease of the skin. First-line treatment of systemic corticosteroids may cause serious adverse events.
Peng Cao, Wenjing Xu, Litao Zhang
semanticscholar +1 more source
Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases [PDF]
, 2018 Introduction: Rituximab (RTX) is a monoclonal antibody targeting CD20, a transmembrane protein expressed on B cells, causing B cell depletion. RTX has shown great efficacy in studies of pemphigus vulgaris, but data of pemphigoid diseases are limited ...
Euverman, H. Ilona +4 more
core +17 more sources
JAMA dermatology, 2022 Importance Bullous pemphigoid is a difficult-to-treat autoimmune blistering skin disease that predominantly affects older adults and is associated with an increased mortality rate. Objective To examine the safety and therapeutic potential of nomacopan,
C. Sadik +12 more
semanticscholar +1 more source
Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid
Acta Dermato-Venereologica, 2021 Massive recruitment of eosinophils into the dermis is a hallmark of bullous pemphigoid pathogenesis. Identifying the chemoattractant(s) guiding eosinophils into the skin in bullous pemphigoid is a prerequisite to therapeutic targeting of eosinophil ...
Jasper Pruessmann +8 more
doaj +1 more source
Case Reports in Dermatology, 2022 Bullous pemphigoid is the most common acquired bullous disease with an autoimmune basis and a tendency to involve mostly old people. By rising incidence of diabetes all over the world, consumption of antidiabetes medications has also increased.
Kamran Balighi +4 more
doaj +1 more source
The Intriguing Links between Psoriasis and Bullous Pemphigoid
Journal of Clinical Medicine, 2022 The coexistence of psoriasis with autoimmune bullous diseases (AIBDs), particularly bullous pemphigoid (BP), has been documented in case reports and series, as well as in epidemiological studies. The onset of psoriasis precedes that of BP in the majority
C. Maronese +5 more
semanticscholar +1 more source
Evaluating risk of bullous pemphigoid after mRNA COVID‐19 vaccination
British Journal of Dermatology, 2022 Our results suggest mRNA COVID-19 vaccination is not associated with increased risk of new-onset bullous pemphigoid. Hopefully, health care professionals may use the findings reported herein to counsel patients experiencing vaccine hesitancy for concerns
Morgan Birabaharan +4 more
semanticscholar +1 more source
Interventions for bullous pemphigoid [PDF]
Cochrane Database of Systematic Reviews, 2003 Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the West. Oral steroids are the standard treatment.This is an update of the review published in 2005.To assess treatments for bullous pemphigoid.In August 2010 we updated our searches of the Cochrane Skin Group Specialised Register, the Cochrane Central Register of Controlled ...
Khumalo, N. +5 more
openaire +9 more sources